By physician referral or invitation only

IBD Pregnancy Registry

The purose of this study is to determine if in utero biologic and immunomodulator exposure leads to higher rates of malignancy, infection, immune mediated disease, neurologic disorders and other health issues out to 18 years from exposure

Age & Gender

0 years ~ 99 years
Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Millie Long
Department of Medicine

Study Type

Clinical or Medical
Registry

Study Topics

Stomach, Digestion and Gut Health
Pregnancy

IRB Number

07-1276

ClinicalTrials.gov

NCT00904878

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.